With that in mind, let's examine two pharma stocks that are incredibly cheap and which are worth buying right now, assuming ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

Recent health news highlights include HIV transmission via organ transplants in Brazil, Sanofi discussing a sale of its ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

West Pharmaceutical Services' stock has been sluggish, trading near its 52-week low, with analysts downgrading estimates and ...

Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of ...

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The ...

On Friday, Vincerx Pharma Inc (VINC) stock saw a modest uptick, ending the day at $0.39 which represents no change from the prior close of of $0.39. The stock opened at $0.39 and touched a low of ...

On Friday, Urogen Pharma Ltd (URGN) stock saw a modest uptick, ending the day at $12.6 which represents a slight increase of $0.69 or 5.79% from the prior close of $11.91. The stock opened at $11.82 ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...

BALLERUP, Denmark-- ( BUSINESS WIRE )--LEO Pharma today announced its commitment to achieving a net-zero climate target by ...